Table 1.
Relationship between clinicopathological characteristics and expression of OTUB2 in gastric cancer (n = 63).
| Expression of OTUB2 | P value | ||
|---|---|---|---|
| High (n = 32) | Low (n = 31) | ||
| Gender | |||
| Male | 20 | 22 | 0.4760 |
| Female | 12 | 9 | |
| Age (years) | |||
| <55 | 6 | 7 | 0.7073 |
| ≥55 | 26 | 24 | |
| BMI | |||
| <24 | 15 | 17 | 0.5271 |
| ≥24 | 17 | 14 | |
| Tumor location | |||
| Upper third | 7 | 6 | 0.6750 |
| Middle third | 15 | 12 | |
| Lower third | 10 | 13 | |
| Tumor size (cm) | |||
| ≤3 | 17 | 25 | 0.0205* |
| >3 | 15 | 6 | |
| Tumor T stage | |||
| 1 + 2 | 16 | 28 | <0.001*** |
| 3 + 4 | 16 | 3 | |
| Tumor N stage | |||
| 0 | 13 | 21 | 0.0309* |
| 1 + 2 + 3 | 19 | 10 | |
| AJCC stage | |||
| I + II | 20 | 28 | 0.0095** |
| III + IV | 12 | 3 | |
| Differentiation | |||
| Well-moderately | 10 | 9 | 0.8475 |
| Poorly | 22 | 22 | |
Statistical significance was determined by t test and chi-square test. *P < 0.05, **P < 0.01, ***P < 0.001.